GlassScriptPhysician profile
Shaun Swindler
NPI 1225272347
$718.76
in general payments reported to CMS, 2019-2025
15 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.28 · 2022: $215 · 2023: $122 · 2024: $184 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $168.83 | 2022-2024 | Durysta, Vuity, Alphagan P |
| Alcon Vision LLC | $121.95 | 2019-2025 | Rocklatan, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $64.42 | 2022-2025 | Vyzulta, Prolensa, Miebo |
| Lkc Technologies, INC. | $56.79 | 2025 | |
| Genentech USA, INC. | $43.22 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $37.56 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $34.61 | 2019 | |
| Horizon Therapeutics Plc | $34.25 | 2022-2023 | Tepezza |
| Allergan, INC. | $28.55 | 2019 | |
| Rayner Intraocular Lenses Limited | $26.57 | 2024 | Rayone Emv, Omidria, Rayone Aspheric |
| Glaukos Corporation | $26.14 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Oyster Point Pharma, INC. | $23.98 | 2022 | |
| Amgen INC. | $21.30 | 2024 | Tepezza |
| Rxsight INC | $18.47 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Swindler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.